Cure CJD Parliamentary Reception

Support the scientific breakthrough and help us fund PRN100 clinical trial phase II

Together we can make an impact in the fight against this disease

Cure CJD Parliamentary Reception

Thames Pavilion, House of Commons, 7th July 2026

A short intro needed here – Aims of the event and a bit about CJD and the campaign

The reception brought together individuals and families who have experienced CJD first-hand, Cure CJD’s supporters, policy experts and parliamentarians to demonstrate their unified commitment to supporting the MRC Prion Unit’s world-leading research and to finally curing CJD and prion diseases.

Purpose of the event

Interviews with those affected by CJD

Woman with CJD

Over 100 people have signed up to attend, and have had very strong interest from MPs and the House of Lords, including:

Over 80 people attended, including 30 parliamentarians and representatives from health organisations. This included:

Speakers at the event

During the event, there were presentations from:

500px-Official_portrait_of_Baroness_Stedman-Scott_crop_2,_2025

Baroness Deborah Stedman-Scott
House of Lords

ed-sawyer 500px

Edward Sawyer
Cure CJD Commitee

500px-Official_portrait_of_Stuart_Andrew_crop_2,_2021
The Rt Hon Stuart Andrew MP
Shadow Secretary of State for Health and Social Care
John Collinge
Professor John Collinge
(MRC Prion Unit)
UK Parliament logo

Edward Sawyer (Political Director)

UK Parliament logo

Keynote Speaker (MP)
Details to follow

During the event there will be presentations from Professor John Collinge (MRC Prion Unit), Charlotte Saigne (Chair of The Cure CJD campaign) and a keynote speaker (MP)

More details and content to follow!

Cure CJD Parliamentary Reception

The Cure CJD Parliamentary Reception

Treatment is within reach, but we need your support

We need £10 million to take PRN100 (a potential treatment) to clinical trials phase II.

Prions in the brain - PRN100 Treatment - Cure CJD

Donate now

Make a one-off or monthly donation and help us to cure CJD and Prion Diseases.